For reprint rights or to purchase a copy of your Daily Journal photo, email jeremy@reprintpros.com for prices or call 949-702-5390.

To buy more copies, call 866-531-1492 or email subscribe@dailyjournal.com
This is the property of the Daily Journal Corporation and fully protected by copyright. It is made available only to Daily Journal subscribers for personal or collaborative purposes and may not be distributed, reproduced, modified, stored or transferred without written permission. Please click "Reprint" to order presentation-ready copies to distribute to clients or use in commercial marketing materials or for permission to post on a website. and copyright (showing year of publication) at the bottom.
Subscribe to the Daily Journal for access to Daily Appellate Reports, Verdicts, Judicial Profiles and more...

Corporate

Oct. 11, 2013

Stradling Yocca handles two biotech IPOs in as many weeks

The firm is advising a pair of San Diego-based biotech companies in their recently announced bids to go public. Biocept and Tandem Diabetes Care are doing so amid an industry boom.


By Dominic Fracassa


Daily Journal Staff Writer


Stradling Yocca Carlson & Rauth PC has helped two San Diego-based biotechnology companies in the past two weeks announce plans to conduct initial public offerings.


At least eight biotech companies with headquarters in the life sciences hub of San Diego have taken to the public markets in 2013.


Tandem Diabetes Care Inc. disclosed its IPO plans Monday. The company, which develops cons...

To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!

Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)

Already a subscriber?

Enewsletter Sign-up



By using our website, you agree to our use of cookies in accordance with our cookie policy. You can learn more about how we use cookies by reviewing our Privacy Policy here.